Moderna
MRNA
MRNA
945 hedge funds and large institutions have $31.1B invested in Moderna in 2024 Q2 according to their latest regulatory filings, with 127 funds opening new positions, 330 increasing their positions, 302 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% more repeat investments, than reductions
Existing positions increased: 330 | Existing positions reduced: 302
0.35% less ownership
Funds ownership: 68.68% → 68.33% (-0.35%)
16% less call options, than puts
Call options by funds: $1.56B | Put options by funds: $1.86B
Holders
945
Holding in Top 10
13
Calls
$1.56B
Puts
$1.86B
Top Buyers
| 1 | +$898M | |
| 2 | +$97.5M | |
| 3 | +$68.9M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$67.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$62.5M |
Top Sellers
| 1 | -$598M | |
| 2 | -$179M | |
| 3 | -$153M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$143M |
| 5 |
MCMC
Matrix Capital Management Company
Portsmouth,
New Hampshire
|
-$77.8M |